Stem Cell Manufacturing Market - Trends Forecast Till 2028

Market Overview

Global Stem Cell Manufacturing market is anticipated to reach USD 11.5 billion in 2021 growing at a CAGR of 9.5% during the forecasting period, 2021-2028.

Stem cells are cells of human body that are able to develop and differentiate into any cell type. They are totipotent in nature and can develop and differentiate into a cell ranging from a neuron to an epidermal cell. Adult stem cells are also called as somatic stem cell. Adult stem cell are of 3 types being Hematopoietic Stem Cells (Blood Stem Cells), Mesenchymal Stem Cells, Neural Stem Cells, Epithelial Stem Cells, Skin Stem Cells. Stem cell manufacturing deals with the technologies required to transfer the current Stem Cell tissue culture into clinical environment.

Due to an increased investment in the sector along with increased awareness and technological advancements in the sector are some of the factors that have supported long-term expansion for Stem Cell Manufacturing industry.

Key Findings

Global Stem Cell Manufacturing market is segmented into Product, Application, End User and geography.

Product segment is segmented into Consumables, Instrument, HSCs, MSCs, iPSCs, ESCs

Application segment is segmented into Research, Clinical (Autologous, Allogenic), and Cell & Tissue Banking

End-User segment is segmented into Pharma & Biotech, Hospitals, Tissue Bank

Geographically, global Stem Cell Manufacturing market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Competitive Landscape

Key players in global Stem Cell Manufacturing market are Thermo Fisher Scientific (US), Merck Millipore (Germany), Lonza Group AG (Switzerland), Danaher Corporation (US), Sartorius AG (Germany), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), Stemcell Technologies (Canada), Fujifilm Holdings Corporation (Japan), Miltenyi Biotec (Germany), Terumo BCT Inc. (US), Corning Inc. (US), Bio-Techne Corporation (US), Takara Bio Group (Japan), Eppendorf AG (Germany), Getinge (Sweden), Himedia Laboratories (India), Anterogen (South Korea), Cellgenix GMBH (Germany) and Promocell (Germany) among others.

Reasons to Acquire

• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
• Gain authentic and granular data access for Stem Cell Manufacturing market so as to understand the trends and the factors involved behind changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope